Mangoceuticals, Inc.
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.09 | $68,757 | -$260,506 |
| 2026 Q1 | -0.34 | $67,864 | -$1M |
| 2025 Q4 | -0.19 | $94,360 | -$1M |
| 2025 Q3 | -0.69 | $84,246 | -$1M |
| 2025 Q2 | -0.54 | $168,109 | -$1M |
| 2025 Q1 | -1.05 | $109,306 | -$2M |
| 2024 Q4 |
| -0.60 |
| $105,247 |
| -$1M |
| 2024 Q3 | -0.99 | $133,368 | -$1M |